Bright Minds Biosciences Inc (DRUG) — Defensive Interval Ratio
Bright Minds Biosciences Inc (DRUG) has a Defensive Interval Ratio of 125 days as of March 2026. Defensive assets of $1.31 Million (cash $-, short-term investments $172.38K, receivables $1.14 Million) cover 125 days of daily cash needs of $10.49K/day. See how liquid is Bright Minds Biosciences Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bright Minds Biosciences Inc Defensive Interval Ratio (2021–2025)
This chart shows how Bright Minds Biosciences Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 125 days, meaning defensive assets of $1.31 Million can fund 125 days of operations without new revenue. See Bright Minds Biosciences Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Bright Minds Biosciences Inc (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bright Minds Biosciences Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Bright Minds Biosciences Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 74 days | $475.00K | $6.40K/day | $- | $61.93K | ▲ +40 days |
| 2024 | 35 days | $50.22K | $1.45K/day | $- | $- | ▼ -125 days |
| 2023 | 160 days | $123.23K | $769.47/day | $- | $86.25K | ▲ +100 days |
| 2022 | 60 days | $242.03K | $4.03K/day | $- | $86.25K | ▼ -52 days |
| 2021 | 112 days | $196.40K | $1.75K/day | $- | $86.25K | — |